TC-2216

TC-2216
Systematic (IUPAC) name
8-pyridin-3-yl-1,8-diazaspiro[4.4]nonane
Clinical data
Identifiers
PubChem CID 10176607
Chemical data
Formula C12H17N3
203.283
 Yes (what is this?)  (verify)

TC-2216 is a drug developed by Targacept which acts as a partial agonist at neural nicotinic acetylcholine receptors and is being researched for the treatment of anxiety and depression.[1]

References

  1. Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372.